Gladius Therapeutics, Inc. — Form D

Gladius Therapeutics, Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-22. The offering totals $300K, of which $300K was reported sold. Industry: Other Health Care.

Offering

• Filed: 2023-08-22
• Form: D
• Accession: 0001986426-23-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $300K
• Amount sold: $300K
• Investors: 4
• Date of first sale: 2023-08-14
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-490377

Issuer

• Name: Gladius Therapeutics, Inc.
• CIK: 0001986426
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2023
• Address: B+LABS, FLOOR 2, PHILADELPHIA, PA, 19104
• Phone: 215-518-3590

Officers, directors & promoters (3)

More

• CIK 1986426 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search